Brief: Wilex subsidiary Heidelberg Pharma and Nordic Nanovector enter into collaboration

Heidelberg Pharma AG

26/10/2016 06:01

Oct 26 (Reuters) - Wilex AG  WL6G.DE : 
    * Subsidiary Heidelberg Pharma and Nordic Nanovector 
 NANOV.OL  enter into collaboration to develop novel antibody 
drug conjugates (ADC) 
    * Collaboration aims at developing novel antibody drug 
conjugates (ADCS) to treat leukemias 
 
Source text for Eikon:  ID:nEQcbC9t2  
Further company coverage:  WL6G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))